DOLAN OLIVER (Senior Vice President, Finance) sold 31.2% of their position (7.35K shares) of KORRO BIO, INC. on the open market
Open‑market sale worth $99.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/10/2026ACC: 0001193125-26-387852
Officer· Senior Vice President, Finance
Since Feb 2026
-7.35K
Net shares
Net seller
$99.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
7.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.35K
Price / share
$13.51
Trade value
$99.29K
% of position
31.1%
9/8/2026
23.60K→16.25K
Common Stock
Direct
Shares
−6.00
Price / share
$13.60
Trade value
$81.62
% of position
0.0%
9/9/2026
16.25K→16.25K
Total
Net shares
−7.35K
Net value
-$99.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/8/2026 | S · Sale | −7.35K | $13.51 | $99.29K | 31.1% | 23.60K | 16.25K |
| Common Stock Direct | 9/9/2026 | S · Sale | −6.00 | $13.60 | $81.62 | 0.0% | 16.25K | 16.25K |
| Total | −7.35K | -$99.37K | ||||||
Derivative Transactions0
No derivative transactions reported